ArticleBMC pregnancy and childbirth2025
The impact of prenatal ultrasound screening on termination of pregnancy with and without feticide: a retrospective analysis.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProvision and uptake of antenatal screening is nonuniform in Austria, as there is no national screening program. The aim of the study was to evaluate the influence of prenatal ultrasound screening methods on the time of diagnosis and therefore the rate of feticide in pregnancies with fetal malformations.
methodRetrospective data analysis of terminations of pregnancies (TOP) with and without feticide due to fetal structural anomalies at a single tertiary care referral center in Austria between 2007 and 2020.
resultsOver the study period, the number of TOPs increased overall, and a nonsignificant rise in the rate of feticide was observed. Women who underwent TOP without feticide significantly more often had first trimester screening; in particular, 588 (86%) cases compared to 121 (57%) with feticide (p < 0.001). Furthermore, in the subgroup of cases diagnosed after 20 weeks of pregnancy (WoP), a significant association between cases without a mid-trimester anomaly scan and TOP with feticide was found. Gestational age at diagnosis was influenced by the type of malformation and therefore the affected organ system.
conclusionFirst trimester screening is critical in early fetal assessment and preventing unnecessary late terminations and feticide. Mid-trimester anomaly scan further increases the early detection of fetal malformations, especially those that become apparent later in pregnancy. Consequently, comprehensive counselling regarding the benefits of prenatal ultrasound screening should be provided to all pregnant women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.